Title: Crystal structures of a stabilized β1-adrenoceptor bound to the biased agonists bucindolol and carvedilol.
Journal: Structure (London, England : 1993) 20120509
Title: β-blockers in stage B: a precursor of heart failure.
Journal: Heart failure clinics 20120401
Title: Combinatorial pharmacogenetic interactions of bucindolol and β1, α2C adrenergic receptor polymorphisms.
Journal: PloS one 20120101
Title: Predicting in vivo cardiovascular properties of β-blockers from cellular assays: a quantitative comparison of cellular and cardiovascular pharmacological responses.
Journal: FASEB journal : official publication of the Federation of American Societies for Experimental Biology 20111201
Title: Which beta-blocker is most effective in heart failure?
Journal: Cardiovascular drugs and therapy 20100801
Title: An alpha2C-adrenergic receptor polymorphism alters the norepinephrine-lowering effects and therapeutic response of the beta-blocker bucindolol in chronic heart failure.
Journal: Circulation. Heart failure 20100101
Title: Pharmacogenetic effect of an endothelin-1 haplotype on response to bucindolol therapy in chronic heart failure.
Journal: Pharmacogenetics and genomics 20090101
Title: Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Journal: Journal of medicinal chemistry 20081009
Title: A polymorphism within a conserved beta(1)-adrenergic receptor motif alters cardiac function and beta-blocker response in human heart failure.
Journal: Proceedings of the National Academy of Sciences of the United States of America 20060725
Title: Beta-adrenoceptor antagonists in elderly patients with chronic heart failure: therapeutic potential of third-generation agents.
Journal: Drugs & aging 20060101
Title: American Association for the Advancement of Science meeting. DNA tells story of heart drug failure.
Journal: Science (New York, N.Y.) 20050225
Title: Clinical trials update from the Heart Failure Society of America: EMOTE, HERB-CHF, BEST genetic sub-study and RHYTHM-ICD.
Journal: European journal of heart failure 20041201
Title: Effect of baseline or changes in adrenergic activity on clinical outcomes in the beta-blocker evaluation of survival trial.
Journal: Circulation 20040914
Title: Adverse effects of beta-blocker therapy for patients with heart failure: a quantitative overview of randomized trials.
Journal: Archives of internal medicine 20040712
Title: Beta blockers as anti-arrhythmic agents.
Journal: Heart failure reviews 20040401
Title: Myocardial contractile reserve by dobutamine stress echocardiography predicts improvement in ejection fraction with beta-blockade in patients with heart failure: the Beta-Blocker Evaluation of Survival Trial (BEST).
Journal: Circulation 20031111
Title: How should subgroup analyses affect clinical practice? Insights from the Metoprolol Succinate Controlled-Release/Extended-Release Randomized Intervention Trial in Heart Failure (MERIT-HF).
Journal: Cardiac electrophysiology review 20030901
Title: Failure of benefit and early hazard of bucindolol for Class IV heart failure.
Journal: Journal of cardiac failure 20030801
Title: Partial agonist activity of bucindolol is dependent on the activation state of the human beta1-adrenergic receptor.
Journal: Circulation 20030722
Title: Catecholamine release in human heart by bupropion.
Journal: European journal of pharmacology 20030425
Title: Beta-blockers in heart failure: how far have we progressed?
Journal: Postgraduate medicine 20021101
Title: [Treatment of heart failure: an update].
Journal: Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology 20020701
Title: Bucindolol displays intrinsic sympathomimetic activity in human myocardium.
Journal: Circulation 20020521
Title: Differential effects of bucindolol and carvedilol on noradenaline-induced hypertrophic response in ventricular cardiomyocytes of adult rats.
Journal: The Journal of pharmacology and experimental therapeutics 20020401
Title: Bucindolol exerts agonistic activity on the propranolol-insensitive state of beta1-adrenoceptors in human myocardium.
Journal: The Journal of pharmacology and experimental therapeutics 20020301
Title: Effects of beta-blocker therapy in severe chronic heart failure.
Journal: The New England journal of medicine 20010927
Title: [Role of beta-blockers in the treatment of chronic heart heart failure].
Journal: Orvosi hetilap 20010916
Title: Nebivolol, bucindolol, metoprolol and carvedilol are devoid of intrinsic sympathomimetic activity in human myocardium.
Journal: British journal of pharmacology 20010801
Title: [Effect of carvedilol on survival in severe chronic heart failure. A trial of the beta-blocker bucindolol in patient with advanced heart failure].
Journal: Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology 20010801
Title: Beta-blocker trials seem to be in conflict.
Journal: Circulation 20010612
Title: Bucindolol, a nonselective beta 1- and beta 2-adrenergic receptor antagonist, decreases beta-adrenergic receptor density in cultured embryonic chick cardiac myocyte membranes.
Journal: Journal of cardiovascular pharmacology 20010601
Title: Expanding indications for beta-blockers in heart failure.
Journal: The New England journal of medicine 20010531
Title: [Adrenergic beta inhibitors in heart insufficiency: which and when?].
Journal: Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology 20010301
Title: Receptor pharmacology of carvedilol in the human heart.
Journal: Journal of cardiovascular pharmacology 19920101
Title: Comparison of the haemodynamic effects of bucindolol, propranolol and pindolol in healthy volunteers.
Journal: British journal of clinical pharmacology 19851201
Title: Differential cardioprotective properties of the l- and d- enantiomers of bucindolol in a canine model of heart failure.
Journal: Archives internationales de pharmacodynamie et de therapie 19850501
Title: Beneficial effects of bucindolol in a canine model of pentobarbital-induced heart failure.
Journal: Archives internationales de pharmacodynamie et de therapie 19810301
Title: Liggett SB, et al. A polymorphism within a conserved beta(1)-adrenergic receptor motif alters cardiac function and beta-blocker response in human heart failure. Proc Natl Acad Sci U S A. 2006 Jul 25;103(30):11288-93.
